Swayampakula Ramakanth

Stock Analyst at HC Wainwright & Co.

(0)
# 4380
Out of 5,333 analysts
608
Total ratings
30.79%
Success rate
-12.58%
Average return
90 Stocks
Name Action PT Current % Upside Ratings Updated
PSNL Personalis
Maintains: Strong Buy
8 9
5.17 74.08% 15 May 7, 2025
CORT Corcept Therapeutics
Maintains: Buy
150 145
71.4 103.08% 22 May 6, 2025
EKSO Ekso Bionics Holding...
Maintains: Buy
9 4
0.41 875.61% 15 May 6, 2025
XFOR X4 Pharmaceuticals
Maintains: Strong Buy
2 7
3.3 112.12% 16 May 2, 2025
IPHA Innate Pharma
Reiterates: Buy
12 11
2.39 360.25% 16 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.45 1011.11% 11 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
1.05 185.71% 2 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
1.46 858.9% 12 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
1.19 194.12% 4 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
27 27
10.5 157.14% 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
2.21 759.73% 14 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 15 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 13
0.16 8025% 11 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 1
0.36 177.78% 9 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
17.54 42.53% 18 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.36 341.18% 10 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.79 150.9% 14 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.09 358.72% 8 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
17.32 90.53% 7 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
9.89 102.22% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 6
0.17 3429.41% 15 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
5.11 389.24% 13 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
20.73 92.96% 5 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
1.37 848.91% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 24
14.35 67.25% 12 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.45 1011.11% 14 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
0.68 1076.47% 20 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
46 46
6.7 586.57% 11 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
26.35 165.65% 12 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110 110
71.54 53.76% 3 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
41.9 43.2% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
8.19 302.93% 18 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.32 316.67% 6 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.69 1349.28% 12 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 10 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
1.82 504.4% 11 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.57 777.19% 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Aug 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1 1
n/a n/a 11 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
7.42 48.25% 8 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
2.08 861.54% 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 5 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 23
n/a n/a 9 Jan 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
2.76 226.09% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 32
n/a n/a 10 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 12 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 6 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
n/a n/a 3 May 15, 2023